Literature DB >> 16434510

The science behind 25 years of ovarian stimulation for in vitro fertilization.

Nick S Macklon1, Richard L Stouffer, Linda C Giudice, Bart C J M Fauser.   

Abstract

To allow selection of embryos for transfer after in vitro fertilization, ovarian stimulation is usually carried out with exogenous gonadotropins. To compensate for changes induced by stimulation, GnRH analog cotreatment, oral contraceptive pretreatment, late follicular phase human chorionic gonadotropin, and luteal phase progesterone supplementation are usually added. These approaches render ovarian stimulation complex and costly. The stimulation of multiple follicular development disrupts the physiology of follicular development, with consequences for the oocyte, embryo, and endometrium. In recent years, recombinant gonadotropin preparations have become available, and novel stimulation protocols with less detrimental effects have been developed. In this article, the scientific background to current approaches to ovarian stimulation for in vitro fertilization is reviewed. After a brief discussion of the relevant aspect of ovarian physiology, the development, application, and consequences of ovarian stimulation strategies are reviewed in detail.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434510     DOI: 10.1210/er.2005-0015

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  108 in total

1.  Research resource: interactome of human embryo implantation: identification of gene expression pathways, regulation, and integrated regulatory networks.

Authors:  Signe Altmäe; Jüri Reimand; Outi Hovatta; Pu Zhang; Juha Kere; Triin Laisk; Merli Saare; Maire Peters; Jaak Vilo; Anneli Stavreus-Evers; Andres Salumets
Journal:  Mol Endocrinol       Date:  2011-11-10

2.  A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only.

Authors:  Fei Gong; Sufen Cai; Shunji Zhang; Changfu Lu; Ge Lin; Guangxiu Lu
Journal:  J Assist Reprod Genet       Date:  2012-02-09       Impact factor: 3.412

3.  Exposing cultured mouse ovarian follicles under increased gonadotropin tonus to aromatizable androgens influences the steroid balance and reduces oocyte meiotic capacity.

Authors:  Sergio Romero; Johan Smitz
Journal:  Endocrine       Date:  2010-07-20       Impact factor: 3.633

Review 4.  Is there a recommended maximum starting dose of FSH in IVF?

Authors:  Luk Rombauts
Journal:  J Assist Reprod Genet       Date:  2007-06-17       Impact factor: 3.412

Review 5.  Ovarian germline stem cells: an unlimited source of oocytes?

Authors:  Carol B Hanna; Jon D Hennebold
Journal:  Fertil Steril       Date:  2014-01       Impact factor: 7.329

6.  Effect of cumulus cell removal 4 h post-insemination on fertilization and embryo quality: a prospective randomized sibling-oocyte study.

Authors:  Yamei Xue; Xiaomei Tong; Lingying Jiang; Haiyan Zhu; Lingyun Yang; Songying Zhang
Journal:  J Assist Reprod Genet       Date:  2013-07-19       Impact factor: 3.412

Review 7.  Ovarian stimulation for in vitro fertilization alters the protein profile expression in endometrial secretion.

Authors:  Ming-Qing Li; Li-Ping Jin
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

Review 8.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

9.  Mild/minimal stimulation protocol for ovarian stimulation of patients at high risk of developing ovarian hyperstimulation syndrome.

Authors:  L Rinaldi; F Lisi; H Selman
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

10.  MicroRNAs miR-30b, miR-30d, and miR-494 regulate human endometrial receptivity.

Authors:  Signe Altmäe; Jose A Martinez-Conejero; Francisco J Esteban; Maria Ruiz-Alonso; Anneli Stavreus-Evers; Jose A Horcajadas; Andres Salumets
Journal:  Reprod Sci       Date:  2012-08-17       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.